Other Members

Read More.

His key research interests include preventive oncology in relation to cervical cancer.
Read More.

Her current research focuses on strategies to eliminate cervical cancer in low resource setting and impact of HPV vaccination in cervical cancer screening.

Read More.

His key research interest includes clinical trials in cervical cancer.
Read More.

His area of expertise resides mainly in Drug development, Translational Glycoimmunology, Proteomics and Glycomics in gynaecological cancer.
Read More.

Santu Kumar Saha: He is currently pursuing an Newton Fellowship under the supervision of Professor Nicola Curtin at Newcastle University and in collaboration with Asima Mukhopadhyay, KolGOTrg.His work includes hypoxia and radiosensitization using PARP inhibitors in cervical cancers.
Read More.

Her previous research work includes basic and translational studies in cervical cancer. Currently she is working on DDR in ovarian cancer at Newcastle University and in collaboration with Asima Mukhopadhyay, KolGOTrg.
Read More.

Her key research interest includes neuro-inflammation, immunology and cancer biology in relation to cervical and ovarian cancer.

Read More.

Her previous and current research interest includes cervical cancer preventions.
Read More.

His key research interest includes cellular metabolism in ovarian cancer and therapeutic targets.

Her key research area focuses on clinical trials in relation to ovarian and cervical cancer.
Read More.

Unit head and Incharge Genital Cancer control Unit, King George’s Medical University, Lucknow
Vice President Association of Gyne Oncologists of India
Vice President Lucknow Obstetrics and Gynaecology Society
Read More.

Dr. Damayanti Das Ghosh is presently studying whether any correlation is present between stemness and presence of GOF mutant p53 and, whether such correlation is associated with chemoresistance in high grade serous ovarian cancer. Her second work is related to developing organoids from ovarian and cervical tumors. In cancer research, organoids can be used for both studying basic biology of the disease and for testing drug-sensitivity. She is also working on TCGA Data-mining on ovarian and endometrial cancer. Read More.

His key research area focuses on clinical trials in relation to ovarian and cervical cancers.
Read More.

Dr Biswarup Basu is Senior Scientific Officer at CNCI and his area of interest is deciphering neuronal regulations on cancer progression. He is engaged in identifying key proteins in autophagy and neuro-endocrine pathways that may serve as potential biomarkers and targets against cancer metastasis in breast and ovarian cancers. Dr Basu is also working on natural compounds with anticancer properties in ovarian tumor models. His other research interest involves the development of biomaterials to accelerate wound healing and facilitate sustained delivery of oral drugs. Read More.

Her key research area focuses on clinical trials in relation to ovarian and cervical cancers.
Read More.

Read More.

His key research area focuses on clinical trials in relation to ovarian and cervical cancers.
Read More.

Adequately trained in management of all Gynaecologic malignancies, pre-invasive conditions, colposcopy and screening tests. Read More

Kailash Narayan a Gynaecological Radiation Oncologist and Professor at the Department of Obstetrics & Gynaecology, University of Melbourne, Australia. He had training in medicine, Biophysics, Experimental pathology and Radiation Oncology. His laboratory research interests have been microvasculature of normal and neoplastic tissues. His clinical research interests have been in the application of histology, MRI and PET in prognosticating and management of gynaecological cancers. His longitudinal observational studies since 1996 have been the source for assessing various radiological and histological prognostic factors and treatment outcomes, showing the highest quality of care and a marked reduction in radiotherapy complications. His observations became the basis of selection of patients for clinical studies. Based on his experimental observations of vascular response to radiation and later clinical observations of cancer treatment failure patterns he hypothesized that tumour cell dissemination could result from the tumour disruption caused by the treatment itself. Read More

Read More.

Dr shashi Kala Tiwary is a highly qualified Obstetrician and Gynaecologist with 1.2 Decades of service experience. She is a member of World Laparoscoy Hospital with experty in Laparoscopy, infertility and general obstetrics and cosmetic gynae. She is a member of KOLGOTRG with special contribution in women Cancer Screening and observership in Preventive Oncology from Tata Medical Centre, Kolkata. Read More

Read More

Read More.

We have lost one of our members Dr. Gouri Sankar Bhattacharyya. He was a renowned oncologist. Due to covid-19, Dr. Bhattacharyya died on April 30, 2021. We pray for his soul to rest in peace. Read More

Global Phase -3 Clinical Trial on Ovarian Cancer is in Progress (Patient Recruitment ongoing). (01/21 to
01/24); Global Phase-2 open label basket study on NSCLC & DLBCL is in progress ( Patient recruitment yet to
start); Survey on Out of Hospital Cardiac Arrest registry (OHCA) and its impact during covid-19 in India (07/21
to 07-23); Awareness of Breast Cancer in different slum areas in Mumbai, (03/19 to 08/19)
PhD Guide: Currently 2 students are working under my supervision in the PhD Program.
Author IDs https://orcid.org/0000-0002-2010-7409; Researcher ID: A-3455-2012; Scopus Author ID:
35444747600
There are 27 peer reviewed Journal Published in several high impact international journals.

Read More